[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# Novartis AG (NVS)

Novartis is reportedly in advanced discussions to acquire Avacta Group's ADC assets for a significant sum, potentially bolstering its oncology pipeline. Additionally, a collaboration with Relation Therapeutics aims to discover drug targets for atopic diseases, involving substantial upfront and milestone payments.

### About Novartis AG
Novartis AG is a global pharmaceutical company focused on developing and manufacturing innovative medicines.  
Novartis AG uses the ticker $NVS for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- Novartis AG (NVS) social dominance hit XXXXXX which is XXX% higher than it's daily average.
- Novartis AG (NVS) market dominance near a 52-week low at XXXXXXX.
- Novartis AG (NVS) trading volume is up XXXXXX% from the previous week.
- Novartis AG (NVS) social dominance is up XXXXXX% from the previous month.
- Novartis AG (NVS) posts created is up XXXXX% from the previous week.
- Novartis AG Price hit a 52-Week high of $XXXXXX for the hour
- Novartis AG Price hit an all time of $XXXXXX for the hour

### Price: $XXXXXX
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/novartis/time-series/close.tsv)  
The stock price is experiencing downward pressure, likely due to Q3 earnings that missed expectations, despite the positive news of the Avidity Biosciences acquisition. The market may be weighing the substantial investment against current financial performance.  

24-Hour: XXXX%
7-Day: -XXXX%
30-Day: -XXXX%

1-Year High: $XXXXXX on 2025-12-03  
1-Year Low: $XXXXX on 2024-12-19  
  
  
### AltRank: XX
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/novartis/time-series/alt_rank.tsv)  
Novartis AG (NVS) is currently AltRank #57 based on combined combined social and market metrics
Daily Average: XXX  
X Week: XX -XXX  
X Month: XX -XXX  
X Months: XX -XXX  
X Year: XX -XXX  
1-Year High: XXXXX on 2025-02-18  
1-Year Low: XX on 2025-11-21  
  
  
### Galaxy Score: XXXXX
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/novartis/time-series/galaxy_score.tsv)  
Current Value: XXXXX  
Daily Average: XX  
X Week: XX -XX  
X Month: XX -XX  
X Months: XX +11  
X Year: XX -X  
1-Year High: XX on 2025-05-20  
1-Year Low: XX on 2025-01-09  
  
  
### Engagements: XXXXXX (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/novartis/time-series/interactions.tsv)  
Current Value: XXXXXX  
Daily Average: XXXXXXX  
X Week: XXXXXXXXX -XX%  
X Month: XXXXXXXXXX +84%  
X Months: XXXXXXXXXX +168%  
X Year: XXXXXXXXXX +170%  
1-Year High: XXXXXXXXX on 2025-11-27  
1-Year Low: XXXXXX on 2025-01-07  

Engagements by network (24h):
News: XXX
Reddit: XXXXX
TikTok: XXXXXX
X: XXXXXX
YouTube: XXXXX

  
  
### Mentions: XXX (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/novartis/time-series/posts_active.tsv)  
Current Value: XXX  
Daily Average: XXX  
X Week: XXXXX -XX%  
X Month: XXXXX -XX%  
X Months: XXXXXX +34%  
X Year: XXXXXX +195%  
1-Year High: XXXXX on 2025-10-27  
1-Year Low: XXX on 2024-12-25  

Mentions by network (24h):
News: XX
Reddit: XXX
TikTok: XXX
X: XXXXX
YouTube: XXX

  
  
### Creators: XXX (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/novartis/time-series/contributors_active.tsv)  
XXX unique social accounts have posts mentioning Novartis AG (NVS) in the last XX hours which is down X% from XXX in the previous XX hours
Daily Average: XXX  
X Week: XXX -XX%  
X Month: XXXXX -XXXX%  
X Months: XXXXX +28%  
X Year: XXXXXX +190%  
1-Year High: XXX on 2025-10-27  
1-Year Low: XXX on 2024-12-25  

The most influential creators that mention Novartis AG in the last XX hours

| Creator                                                                            | Rank | Followers | Posts | Engagements |
| -------                                                                            | ---- | --------- | ----- | ----------- |
| [@RNAiAnalyst](/creator/twitter/RNAiAnalyst)                                       | X    | XXXXXX    | X     | XXXXXX      |
| [@stats_feed](/creator/twitter/stats_feed)                                         | X    | XXXXXXXXX | X     | XXXXX       |
| [@Darwin_Knows](/creator/twitter/Darwin_Knows)                                     | X    | XXX       | XX    | XXXXX       |
| [@ValueSense_io](/creator/twitter/ValueSense_io)                                   | X    | XXXXXX    | X     | XXXXX       |
| [@progresspotentialpossibilities](/creator/youtube/progresspotentialpossibilities) | X    | XXXXXX    | X     | XXXXX       |
| [@Regenbo5en](/creator/twitter/Regenbo5en)                                         | X    | XXXXX     | X     | XXX         |
| [@BentheFidler](/creator/twitter/BentheFidler)                                     | X    | XXXXX     | X     | XXX         |
| [@grok](/creator/twitter/grok)                                                     | X    | XXXXXXXXX | XX    | XXX         |
| [@BioWorld](/creator/twitter/BioWorld)                                             | X    | XXXXXX    | X     | XXX         |
| [@novartis](/creator/youtube/novartis)                                             | XX   | XXXXXX    | XX    | XXX         |

[View More](/list/creators/novartis/100)
  
  
### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/novartis/time-series/sentiment.tsv)  
Current Value: XX%  
Daily Average: XX%  
X Week: XX% -X%  
X Month: XX% +2%  
X Months: XX% +3%  
X Year: XX% +1%  
1-Year High: XX% on 2025-10-26  
1-Year Low: XX% on 2025-11-26  

Most Supportive Themes:
- Acquisition of Avidity Biosciences: (70%) Novartis AG is acquiring Avidity Biosciences for $XX billion, strengthening its neuroscience pipeline.
- Pipeline Advancements: (10%) Novartis AG is presenting new treatments, including for Sjogren's disease, and has advanced its RNA therapeutics.
- Positive Financial Performance: (20%) Novartis AG reported solid sales and core operating income growth in Q3 2025, driven by new cancer medicines.
  
Most Critical Themes:
- Drug Pricing and Access Concerns: (60%) There are discussions and concerns regarding the pricing of Novartis's drug Pluvicto and patient access programs.
- Past Legal Issues: (40%) Novartis AG has faced past settlements related to kickbacks and co-pay fraud.
  
  
  
### Social Dominance: XXXXX%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/novartis/time-series/social_dominance.tsv)  
Current Value: XXXXX%  
Daily Average: XXXXX%  
X Week: XXXXX% +0.03%  
X Month: XXXX% +0.113%  
X Months: XXXX% +0.107%  
X Year: XXXX% +0.106%  
1-Year High: XXXX% on 2025-12-11  
1-Year Low: XXXXX% on 2025-07-01  
  
  
### Market Dominance: XXXXX%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/novartis/time-series/market_dominance.tsv)  
Current Value: XXXXX%  
Daily Average: X%  
1-Year High: XXXX% on 2025-12-02  
1-Year Low: XXXX% on 2025-12-10  
  
  
### Market Cap: $XXXXXXXXXXXXXXX
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/novartis/time-series/market_cap.tsv)  
Current Value: $XXXXXXXXXXXXXXX  
Daily Average: $XXXXXXXXXXXXXXX  
X Week: $XXXXXXXXXXXXXXX -$1.90%  
X Month: $XXXXXXXXXXXXXXX +$3.10%  
X Months: $XXXXXXXXXXXXXXX +$6.70%  
X Year: $XXXXXXXXXXXXXXX +$26%  
1-Year High: $XXXXXXXXXXXXXXX on 2025-12-03  
1-Year Low: $XXXXXXXXXXXXXXX on 2024-12-19  

### Top Novartis AG News
Top news links shared on social in the last XX hours  

*Showing a maximum of X news posts for non-authenticated requests. Use your API key in requests for full results.*  

"Mirum Therapeutics to buy Bluejay Therapeutics for up to $820M - San Francisco Business Times"  
[News Link](https://www.bizjournals.com/sanfrancisco/news/2025/12/09/mirum-bluejay-merger-novartis.html) [@bizjournals](/creator/x/bizjournals) 2025-12-10T01:05Z 228.6M followers, XXX engagements


"Notable analyst calls this week: Novartis Albemarle and Zscaler among top picks Seeking Alpha"  
[News Link](https://seekingalpha.com/news/4529036-notable-analyst-calls-this-week-novartis-albemarle-and-zscaler-among-top-picks) [@SeekingAlpha](/creator/x/SeekingAlpha) 2025-12-06T17:30Z 228.6M followers, 1900 engagements


"Novartis receives FDA approval for Itvisma the only gene replacement therapy for children two years and older teens and adults with spinal muscular atrophy (SMA)"  
[News Link](https://www.prnewswire.com/news-releases/novartis-receives-fda-approval-for-itvisma-the-only-gene-replacement-therapy-for-children-two-years-and-older-teens-and-adults-with-spinal-muscular-atrophy-sma-302625033.html) [@kintintoys](/creator/x/kintintoys) 2025-11-25T12:28Z 228.6M followers, 1474 engagements



### Top Novartis AG Social Posts
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"- still pending QC Results of Novartis Platform study. No baseline AN count reported. Placebos were pooled a tad strange because the platform was done sequentially so each drug had its own PBO but they pooled them for HISCR calc"  
[X Link](https://x.com/SolariumEarth/status/1998957459382391126) [@SolariumEarth](/creator/x/SolariumEarth) 2025-12-11T03:26Z XXX followers, XXX engagements


"Novartis dropped this hepatitis drug years ago. Bluejay picked it up leading to a potential $XXX buyout by Mirum Pharmaceuticals - San Francisco Business Times via @SFBusinessTimes"  
[X Link](https://x.com/rleuty_biotech/status/1998860646981800415) [@rleuty_biotech](/creator/x/rleuty_biotech) 2025-12-10T21:01Z 11.4K followers, XXX engagements


"$NVS Novartis presented P3 Breast Cancer results on 2025-12-09 for Ribociclib More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1998856209475023293) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-12-10T20:43Z 3010 followers, XXX engagements


"✦ ✦ ✦ EMAGIA AUTONOMOUS FINANCE SUMMIT 2025 SPEAKERS ✦ ✦ ✦ Incredible speaker lineup for the TechNVision's Emagia Autonomous Finance Summit 2025 (12 Dec) from WIPRO WNS Honeywell Everest Group ISG Accenture Novartis Sagility UPL Johnson Controls IBM Deloitte India Tech Mahindra HSBC Multiplier AI and many more big companies. Veena Gundavelli Founder & CEO @ Emagia JA Chowdhary Founding Director @ STPI India Dexter Peavy VP O2C Transformation @ Emagia Sivaram Vallampati Corporate SVP @ WNS Global Services Govil Kumar Director Analytics & Planning @ Honeywell Phyllis Saavedra VP Finance"  
[X Link](https://x.com/Value2WealthIND/status/1998818774569611555) [@Value2WealthIND](/creator/x/Value2WealthIND) 2025-12-10T18:15Z 7142 followers, XXX engagements